<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="ame212507" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Animal Model Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">Animal Model Exp Med</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2576-2095</journal-id><journal-id journal-id-type="publisher-id">AME2</journal-id><journal-title-group><journal-title>Animal Models and Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">2096-5451</issn><issn pub-type="epub">2576-2095</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39686556</article-id><article-id pub-id-type="pmc">PMC11680474</article-id>
<article-id pub-id-type="doi">10.1002/ame2.12507</article-id><article-id pub-id-type="publisher-id">AME212507</article-id><article-id pub-id-type="other">AMEM-2024-0055.R2</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Themed Section: Bone Regeneration and Disease Mechanisms</subject><subj-group subj-group-type="heading"><subject>Themed Section: Original Article</subject></subj-group></subj-group></article-categories><title-group><article-title>The decrease in zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1 could accelerate steroid&#x02010;induced osteonecrosis of the femoral head by repressing type&#x02010;H vessel formation via <italic toggle="no">Wnt/&#x003b2;&#x02010;catenin</italic> pathway</article-title><alt-title alt-title-type="left-running-head">Zhang et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="ame212507-cr-0001" contrib-type="author"><name><surname>Zhang</surname><given-names>Guangyang</given-names></name><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame212507-cr-0002" contrib-type="author"><name><surname>Cai</surname><given-names>Yuanqing</given-names></name><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame212507-cr-0003" contrib-type="author"><name><surname>Liang</surname><given-names>Jialin</given-names></name><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame212507-cr-0004" contrib-type="author"><name><surname>Jing</surname><given-names>Zhaopu</given-names></name><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame212507-cr-0005" contrib-type="author"><name><surname>Wei</surname><given-names>Wang</given-names></name><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame212507-cr-0006" contrib-type="author"><name><surname>Lv</surname><given-names>Leifeng</given-names></name><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame212507-cr-0007" contrib-type="author" corresp="yes"><name><surname>Dang</surname><given-names>Xiaoqian</given-names></name><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>dangxiaoqian@xjtu.edu.cn</email></address></contrib><contrib id="ame212507-cr-0008" contrib-type="author" corresp="yes"><name><surname>Song</surname><given-names>Qichun</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2111-5037</contrib-id><xref rid="ame212507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>qichuns@xjtu.edu.cn</email></address></contrib></contrib-group><aff id="ame212507-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Orthopedic Center, The Second Affiliated Hospital of Xi'an Jiaotong University</institution>
<city>Xi'an</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>
Xiaoqian Dang and Qichun Song, Orthopedic Center, Department of Sports Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China.<break/>
Email: <email>dangxiaoqian@xjtu.edu.cn</email> and <email>qichuns@xjtu.edu.cn</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>16</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>7</volume><issue seq="70">6</issue><issue-id pub-id-type="doi">10.1002/ame2.v7.6</issue-id><issue-title>Themed Issue: Bone Regeneration and Disease Mechanisms</issue-title><fpage>802</fpage><lpage>815</lpage><history>
<date date-type="received"><day>26</day><month>2</month><year>2024</year></date>
<date date-type="accepted"><day>08</day><month>10</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2024 The Chinese Association for Laboratory Animal Sciences.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">Animal Models and Experimental Medicine</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:AME2-7-802.pdf"/><abstract><title>Abstract</title><sec id="ame212507-sec-1001"><title>Background</title><p>Zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1 (<italic toggle="yes">ZEB1</italic>) is predominantly found in type&#x02010;H vessels. However, the roles of <italic toggle="yes">ZEB1</italic> and type&#x02010;H vessels in steroid&#x02010;induced osteonecrosis of the femoral head (SONFH) are unclear.</p></sec><sec id="ame212507-sec-2001"><title>Methods</title><p>Human femoral heads were collected to detect the expression of <italic toggle="yes">ZEB1</italic> and the levels of type&#x02010;H vessels. Then, the SONFH model was developed by injecting C57BL/6 mice with lipopolysaccharide and methylprednisolone. Micro&#x02010;computed tomography, angiography, double calcein labeling, immunofluorescence, immunohistochemistry, quantitative real&#x02010;time polymerase chain reaction, and Western blotting were performed to detect the expression of <italic toggle="yes">ZEB1</italic>, the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway, type&#x02010;H vessels, and the extent to which <italic toggle="yes">ZEB1</italic> mediates angiogenesis and osteogenesis. Human umbilical vein endothelial cells were also used to explore the relationship between <italic toggle="yes">ZEB1</italic> and the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway.</p></sec><sec id="ame212507-sec-3001"><title>Results</title><p>We found that <italic toggle="yes">ZEB1</italic> expression and the formation of type&#x02010;H vessels decreased in SONFH patients and in a mouse model. The number of vascular endothelial growth factors in the femoral heads also decreased. Moreover, the bone mineral density, trabecular number, mineral apposition rate, and expression of genes related to osteogenesis decreased. After <italic toggle="yes">ZEB1</italic> knockdown, angiogenesis and osteogenesis decreased. However, the numbers of type&#x02010;H vessels and the extent of angiogenesis and osteogenesis improved after activation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway.</p></sec><sec id="ame212507-sec-4001"><title>Conclusions</title><p>The&#x000a0;ZEB1 expression decreased in SONFH, causing a decrease in type&#x02010;H vessel, and it mediated angiogenesis and osteogenesis by regulating the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway, ultimately accelerating the process of SONFH.</p></sec></abstract><abstract abstract-type="graphical"><p>The application of glucocorticoid could restrain the expression of <italic toggle="yes">ZEB1</italic>, causing a decrease in the expression of <italic toggle="yes">&#x003b2;&#x02010;catenin</italic>, transcription factor&#x02010;4, <italic toggle="yes">C&#x02010;Myc</italic>, and other key genes in the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway, ultimately damaging the formation of type&#x02010;H vessels and aggravating necrosis of the femoral head. However, activation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway promotes the formation of type&#x02010;H vessels and prevents SONFH (steroid&#x02010;induced osteonecrosis of the femoral head).<boxed-text position="anchor" content-type="graphic" id="ame212507-blkfxd-0001"><graphic xlink:href="AME2-7-802-g003.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ame212507-kwd-0001">steroid&#x02010;induced osteonecrosis of the femoral head</kwd><kwd id="ame212507-kwd-0002">type&#x02010;H vessel</kwd><kwd id="ame212507-kwd-0003">Wnt/&#x003b2;&#x02010;catenin pathway</kwd><kwd id="ame212507-kwd-0004">zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>China Postdoctoral Science Foundation
</institution><institution-id institution-id-type="doi">10.13039/501100002858</institution-id></institution-wrap></funding-source><award-id>2021M692575</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Fundamental Research Funds for the Central Universities
</institution><institution-id institution-id-type="doi">10.13039/501100018594</institution-id></institution-wrap></funding-source><award-id>xzy022024016</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82002311</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="0"/><page-count count="14"/><word-count count="7300"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2024</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:28.12.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="AME212507-cit-2001">
<string-name>
<surname>Zhang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>The decrease in zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1 could accelerate steroid&#x02010;induced osteonecrosis of the femoral head by repressing type&#x02010;H vessel formation via <italic toggle="no">Wnt/&#x003b2;&#x02010;catenin</italic> pathway</article-title>. <source>Anim Models Exp Med</source>. <year>2024</year>;<volume>7</volume>:<fpage>802</fpage>&#x02010;<lpage>815</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ame2.12507</pub-id>
</mixed-citation>
</p></notes></front><body id="ame212507-body-0001"><sec id="ame212507-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Nontraumatic osteonecrosis of the femoral head (ONFH) is a severe condition that typically impacts individuals aged &#x0003c;50&#x02009;years, leading to structural changes in the hip, collapse of the femoral head, and impaired joint function. A previous study revealed that more than 10&#x02009;000 individuals in the United States are diagnosed with ONFH annually, accounting for nearly 10% of total hip arthroplasties.<xref rid="ame212507-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Furthermore, the number of Chinese patients affected by this disease reached 8.12 million.<xref rid="ame212507-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Steroid&#x02010;induced osteonecrosis of the femoral head (SONFH) was initially reported in 1953 and has emerged as the predominant cause of ONFH in recent years.<xref rid="ame212507-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> A variety of theories, ranging from lipid metabolism disorders, a decreased osteogenic potential of bone marrow mesenchymal stem cells (BMSC), inadequate blood supply, inflammation, and cell apoptosis have been proposed for the pathogenesis of SONFH. However, the precise pathological mechanisms remain elusive. Therefore, further research on the pathogenesis of SONFH is needed to develop efficient treatments for patients with this disease.</p><p>Bone is a highly vascularized tissue that enables it to receive vital nutrients, oxygen, growth factors, and hormones from blood circulation. Recent studies have revealed that osteogenesis and angiogenesis are consistently interconnected during the process of bone modeling and remodeling, namely angiogenic&#x02013;osteogenic coupling.<xref rid="ame212507-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Type&#x02010;H vessels, a distinct subtype of capillaries characterized by elevated levels of platelet endothelial cell adhesion molecule&#x02010;1 (<italic toggle="yes">CD31</italic>) and endomucin (<italic toggle="yes">EMCN</italic>), have been demonstrated to coordinate the interplay between osteogenesis and angiogenesis. A decrease in type&#x02010;H vessels was shown to be associated with many orthopedic disorders. Previous studies have shown a notable reduction in the quantity of type&#x02010;H vessels and coupled Osterix+ osteoprogenitors within the hypofunctional periodontal ligament in mice with alveolar bone disuse osteoporosis.<xref rid="ame212507-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Li et&#x000a0;al. demonstrated that injecting slit guidance ligand 3 could improve the integration of tendon and bone, possibly by modulating the coordination between angiogenesis and osteogenesis mediated by type&#x02010;H vessels.<xref rid="ame212507-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Moreover, metformin has been shown to hold promise as a treatment option for fractures. This is because it can stimulate the formation of type&#x02010;H vessels by repressing the activity of <italic toggle="yes">YAP1/TAZ</italic>.<xref rid="ame212507-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Another study successfully constructed a polycaprolactone/hydroxyapatite&#x02010;iminodiacetic acid&#x02010;deferoxamine scaffold and revealed that it could significantly facilitate the development of type&#x02010;H vessels and the expression of coupling factors to stimulate osteogenesis, thereby increasing the regeneration of substantial bone defects in rats.<xref rid="ame212507-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> However, the study investigating the role of type&#x02010;H vessels in the pathogenesis of SONFH is rare.</p><p>The <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway plays a critical role in bone biology, including bone formation, remodeling, and homeostasis. Recently, it has been found to be intricately linked to the pathogenesis of SONFH and the development of type&#x02010;H vessels. The expressions of Runt&#x02010;related transcription factor 2 (<italic toggle="yes">Runx2</italic>) and <italic toggle="yes">&#x003b2;&#x02010;catenin</italic> in the necrotic region of the femoral head were considerably lower than those in the normal region. This suggested that the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway was compromised in the necrotic area.<xref rid="ame212507-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Furthermore, glycyrrhizic acid was shown to modify the differentiation commitment of BMSCs under hyper&#x02010;oxidative stress via activating the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway, ultimately preventing the development of SONFH.<xref rid="ame212507-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Another study revealed that Astragalus polysaccharide could ameliorate SONFH by regulating the miR&#x02010;200b&#x02010;3p&#x02010;mediated <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> signaling.<xref rid="ame212507-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> The relationships between <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> signaling and the processes of osteogenesis and angiogenesis have also been well investigated. Shen et&#x000a0;al. revealed that epidermal growth factor&#x02010;like domain&#x02010;containing protein 6 could stimulate angiogenesis and osteogenesis through <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> signaling and enhance the formation of type&#x02010;H vessels in a tibia distraction osteogenesis model.<xref rid="ame212507-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Wang et&#x000a0;al. constructed a novel decellularized matrix and reported that it could accelerate regeneration of bone defects via osteoclastogenesis, angiogenesis, and neurogenesis by activating <italic toggle="yes">Wnt</italic> signaling.<xref rid="ame212507-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>
</p><p>Zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1 (<italic toggle="yes">ZEB1</italic>) is a zinc finger transcription factor that initiates the epithelial&#x02013;mesenchymal transition process and plays a crucial role in wound healing, fibrosis, and metastasis, as well as growth, development, and various pathological conditions.<xref rid="ame212507-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Previous evidence demonstrated that <italic toggle="yes">ZEB1</italic> was mainly expressed in type&#x02010;H vessels in human and mouse bones, and the specific deletion of <italic toggle="yes">ZEB1</italic> in endothelial cells of mice decreased type&#x02010;H vessel formation in the bone, causing reduced osteogenesis.<xref rid="ame212507-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Another study revealed that a reduction in <italic toggle="yes">ZEB1</italic>&#x02010;mediated vascular endothelial growth factor (<italic toggle="yes">VEGF</italic>) transcription could impair angiogenesis.<xref rid="ame212507-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Similarly, Zhou et&#x000a0;al. prepared a GM/Ac&#x02010;CD/rGO hydrogel and revealed that it could promote osteogenesis and angiogenesis coupling that mediated type&#x02010;H vessels via stimulating the <italic toggle="yes">ZEB1/Notch1</italic> pathway.<xref rid="ame212507-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Additionally, <italic toggle="yes">ZEB1</italic> can interact with transcription factor 4 (<italic toggle="yes">TCF&#x02010;4</italic>) to regulate the transcriptional activity of <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic>&#x02010;related genes.<xref rid="ame212507-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
<italic toggle="yes">ZEB1</italic> can activate the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> signaling pathway by increasing the levels of <italic toggle="yes">&#x003b2;&#x02010;catenin</italic>, <italic toggle="yes">C&#x02010;Myc</italic>, and <italic toggle="yes">cyclin D1</italic>, thereby promoting cell proliferation and migration and inhibiting apoptosis.<xref rid="ame212507-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Therefore, <italic toggle="yes">ZEB1</italic> plays an important role in osteogenesis and angiogenesis; however, its specific involvement in SONFH remains uncertain and requires additional investigation.</p></sec><sec sec-type="methods" id="ame212507-sec-0002"><label>2</label><title>METHODS</title><sec id="ame212507-sec-0003"><label>2.1</label><title>Femoral head collection</title><p>The femoral heads of humans were collected from patients who underwent total hip replacement. Femoral heads from SONFH patients classified as grade 3 or 4 based on the Ficat classification system were collected, and femoral heads from femoral neck fracture patients were selected as controls. Patients with previous bone disease or other physical disease were excluded. Moreover, those who disagreed with the research methods were also excluded. All femoral heads were stored in liquid nitrogen for subsequent analysis.</p></sec><sec id="ame212507-sec-0004"><label>2.2</label><title>Animal models</title><p>Male C57BL/6 mice were obtained from the Laboratory Animal Center of Xi'an Jiaotong University and housed in specific pathogen&#x02010;free conditions (temperature: 20&#x02013;25&#x000b0;C, humidity: 50%&#x02013;60%) with four mice per cage. The mice were divided into four groups randomly after 7&#x02009;days of adaptive feeding. (1) In the SONFH group, the mice were initially treated with lipopolysaccharide (20&#x02009;&#x003bc;g/kg, Sigma&#x02010;Aldrich, MO, USA) via intraperitoneal injection daily for a duration of two consecutive days. Then, methylprednisolone (100&#x02009;mg/kg, Sigma&#x02010;Aldrich) was injected into the gluteus once a day for 2&#x02009;weeks and once every other day for an additional 6&#x02009;weeks. In addition, the mice in this group underwent a sham operation. (2) SONFH + <italic toggle="yes">ZEB1</italic> knockdown group (SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>): the mice were subjected to the same treatments as those in the SONFH group. Moreover, rLV&#x02010;shRNA1&#x02010;m<italic toggle="yes">ZEB1</italic>&#x02010;985 (1&#x02009;&#x000d7;&#x02009;10<sup>8</sup> TU/mL), prepared by Bio&#x02010;Tower Biotechnology (Wuhan, China), was injected once a week (1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> TU each time) into the femoral bone marrow cavity through the femoral intercondylar fossa after anesthesia by intraperitoneal injection of 50&#x02009;mg/kg of sodium pentobarbital (Sigma&#x02010;Aldrich) for the last 4&#x02009;weeks. (3) SONFH + <italic toggle="yes">ZEB1</italic> knockdown + lithium chloride (LiCl) group (SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>+LiCl): LiCl is an activator of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway that inhibits the activity of <italic toggle="yes">GSK&#x02010;3&#x003b2;</italic>. The mice underwent the same procedure as the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> group. Additionally, LiCl (200&#x02009;mg/kg, Sigma&#x02010;Aldrich) was administered by gavage once a day from the seventh week to the end of the experiment. (4) Control group: the mice in the other groups were treated with an equal volume of normal saline, and a sham operation was performed. All the mice received an overdose of anesthesia by intraperitoneal injection of 100&#x02009;mg/kg of sodium pentobarbital (Sigma&#x02010;Aldrich) and then killed in the eighth week, and the femoral heads were obtained and used for further analysis.</p></sec><sec id="ame212507-sec-0005"><label>2.3</label><title>Cell culture</title><p>Human umbilical vein endothelial cells (HUVEC), obtained from the Shanghai National Stem Cell Translational Resource Center (Shanghai, China), were cultured at 37&#x000b0;C in 5% CO<sub>2</sub> in an endothelial cell medium and passaged at 1:3 with 0.25% trypsin. The HUVECs were divided into four groups: (1) the control group, in which the cells were treated with equal amounts of general control lentivirus, was used as the experimental group. (2) In the <italic toggle="yes">ZEB1</italic> knockdown group (si&#x02010;<italic toggle="yes">ZEB1</italic>), the cells in each well were treated with 50&#x02009;&#x003bc;L of lentivirus (1&#x02009;&#x000d7;&#x02009;10<sup>8</sup> TU/mL, rLV&#x02010;shRNA1&#x02010;m<italic toggle="yes">ZEB1</italic>&#x02010;985, Bio&#x02010;Tower) for <italic toggle="yes">ZEB1</italic> knockdown. After 48&#x02009;h of culture and cell passage, the affected HUVECs were reseeded in six&#x02010;well plates at a density of 5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells per well. Then, 6&#x02010;bromoindirubin&#x02010;3&#x02032;&#x02010;oxime (BIO, 5&#x02009;&#x003bc;M, Sigma&#x02010;Aldrich) was applied to activate the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway. (3) In the control + BIO group, the cells were initially treated as the control group and then treated with BIO. (4) <italic toggle="yes">ZEB1</italic> knockdown+BIO group (si&#x02010;<italic toggle="yes">ZEB1</italic>+BIO): the cells in this group were considered as the si&#x02010;<italic toggle="yes">ZEB1</italic> group; then BIO was used. After a 72&#x02010;h incubation period, all the HUVECs were collected for further analyses.</p></sec><sec id="ame212507-sec-0006"><label>2.4</label><title>Quantitative real&#x02010;time polymerase chain reaction</title><p>Total RNA was extracted using TRIzol (Thermo Fisher Scientific, MA, USA) according to the manufacturer's protocol. Then, a Nanodrop (Invitrogen, USA) was used to measure the RNA concentration, and PrimeScript RT Master Mix kits (Takara, Japan) were used for complementary DNA synthesis in accordance with the standard protocol. Quantitative real&#x02010;time polymerase chain reaction (RT&#x02010;qPCR) analysis was performed on a Bio&#x02010;Rad CFX96 qPCR instrument (Bio&#x02010;Rad, Hercules, USA) with an SYBR Select Master Mix kit (Vazyme, Nanjing, China). Glyceraldehyde 3&#x02010;phosphate dehydrogenase was used as the internal control. The primer sequences for the genes investigated in this study are presented in Table&#x000a0;<xref rid="ame212507-supitem-0001" ref-type="supplementary-material">S1</xref>.</p></sec><sec id="ame212507-sec-0007"><label>2.5</label><title>Western blotting</title><p>The proteins were extracted using the standard procedure and quantified using the BCA Protein Assay Kit (Beyotime, Shanghai, China). The proteins were diluted to equal concentration using loading buffer, loaded onto sodium dodecyl sulfate&#x02010;polyacrylamide gel electrophoresis gel, and subsequently transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, USA). After being blocked with 5% bovine serum albumin (Sigma), the proteins were incubated with primary antibodies overnight at 4&#x000b0;C. The PVDF membranes were then washed and incubated with secondary antibodies for 2&#x02009;h at room temperature. An enhanced chemiluminescence assay (Millipore Corporation) was used for identifying the proteins. The primary antibodies employed in this study are presented in Table&#x000a0;<xref rid="ame212507-supitem-0001" ref-type="supplementary-material">S2</xref>.</p></sec><sec id="ame212507-sec-0008"><label>2.6</label><title>Hematoxylin and eosin, immunofluorescence, and immunohistochemistry staining</title><p>The femoral heads were dissociated and then fixed in 10% formalin for 48&#x02009;h. Subsequently, they were decalcified in a water bath at 37&#x000b0;C with 10% ethylenediaminetetraacetic acid (EDTA). The EDTA solution was replaced every 3&#x02009;days until the specimens became soft. Then the femoral heads were embedded in paraffin and sectioned (5&#x02009;&#x003bc;m) following standard procedures; the sections were stained with hematoxylin and eosin (HE, Sigma). The bone lacunae and empty bone lacunae were quantified in three randomly selected visual fields under a 200&#x000d7; microscope in HE&#x02010;stained sections. The percentage of empty bone lacunae was calculated by the ratio of empty bone lacunae to total bone lacunae.</p><p>The sections for immunofluorescence (IF) staining were prepared following the same protocol as for HE staining. After the dewaxing and antigen retrieval procedures, normal goat serum was applied at room temperature for 30&#x02009;min to minimize nonspecific staining. The sections were then incubated overnight at 4&#x000b0;C with primary antibodies against <italic toggle="yes">ZEB1</italic>, <italic toggle="yes">EMCN</italic>, <italic toggle="yes">CD31</italic> or <italic toggle="yes">VEGF</italic>, as specified by the manufacturer's instructions. Subsequently, the sections were incubated with secondary antibodies labeled with Cy3 or fluorescein isothiocyanate, and nuclear staining was performed using 4&#x02032;,6&#x02010;diamidino&#x02010;2&#x02010;phenylindole. The sections were observed using a fluorescence microscope (Leica DMI6000B, Wetzlar, Germany) under dark conditions, and the sections were scanned using a slicing scanner (Pannoramic MIDI, 3DHISTECH, Budapest, Hungary).</p><p>The preparation of sections, dewaxing, and antigen retrieval for immunohistochemistry (IHC) were the same as those for IF staining. Then, the sections were treated with 3% hydrogen peroxide at room temperature for 15&#x02009;min to inhibit endogenous peroxidase activity. Subsequently, the sections were incubated overnight at 4&#x000b0;C with the appropriate diluted primary antibodies against alkaline phosphatase (ALP), Runx2, or Osterix. After incubation, the sections were washed and then incubated again with the corresponding secondary antibodies at 37&#x000b0;C for 30&#x02009;min. Then, the sections were stained with diaminobenzidine and counterstained with hematoxylin. Finally, the dried sections were viewed under a microscope, and images were obtained. The primary antibodies used are presented in Table&#x000a0;<xref rid="ame212507-supitem-0001" ref-type="supplementary-material">S2</xref>.</p></sec><sec id="ame212507-sec-0009"><label>2.7</label><title>Micro&#x02010;computed tomography and micro&#x02010;computed tomography&#x02013;based angiography</title><p>The mouse femoral heads were first removed, fixed in 10% formalin for 48&#x02009;h, soaked in 75% alcohol overnight, and scanned using micro&#x02010;computed tomography (CT) at 70&#x02009;kV in a high&#x02010;resolution system to obtain the original images. The standard body model was also scanned under the same conditions for calibration. Next, the original images were reconstructed using the three&#x02010;dimensional reconstruction software NRecon (version 1.7.4.2, Bruker, Germany) and analyzed via a CT analyzer (version 1.18.8.0, Bruker). The bone mineral density (BMD), bone volume (BV), percentage bone volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), and cortical thickness (Ct.Th), which are related to the bone mass and microstructure, were calculated and analyzed.</p><p>Micro&#x02010;CT&#x02010;based angiography was also performed. First, an intravenous needle was injected into the left ventricle for perfusion when the heart was exposed after anesthesia by intraperitoneal injection of 50&#x02009;mg/kg of sodium pentobarbital (Sigma&#x02010;Aldrich). Then, 37&#x000b0;C normal saline supplemented with 10&#x02009;IU/mL low&#x02010;molecular&#x02010;weight heparin was injected through the auricula dextra, followed by 4% paraformaldehyde and normal saline. Finally, the mice were housed overnight at 4&#x000b0;C after injection of Microfil solution at a rate of 3&#x02009;mL/min. The next day, the right femurs were collected after the muscles and other excess soft tissues around the bone were removed and fixed again in 4% paraformaldehyde for 24&#x02009;h. A 10% EDTA solution was used for decalcification before scanning using micro&#x02010;CT at 70&#x02009;kV. NRecon (version 1.7.4.2, Bruker) and a CT Analyzer (version 1.18.8.0, Bruker) were used for reconstruction and analyses. The vascular volume fraction and blood vessel density were calculated to assess angiogenesis in the femoral heads.</p></sec><sec id="ame212507-sec-0010"><label>2.8</label><title>Double calcein labeling</title><p>Double calcein labeling was conducted to detect the dynamic bone formation of the femoral heads. The calcein (10&#x02009;mg/kg, Beyotime) that was dissolved in 2% sodium bicarbonate solution was administered intraperitoneally in the sixth week of modeling and injected again in an interval of 6&#x02009;days. The femoral heads of the mice were removed and then fixed in 4% paraformaldehyde for 48&#x02009;h. After fixation, the samples were dehydrated and embedded in methyl methacrylate (Macklin, Shanghai, China). The embedded samples were then cut into 10&#x02010;&#x003bc;m sections using a microtome (HistoCore AUTOCUT, Leica). Subsequently, images of the sections were obtained using a laser scanning confocal microscope (Olympus FV3000, Japan).</p></sec><sec id="ame212507-sec-0011"><label>2.9</label><title>Statistical analysis</title><p>The results are presented as mean&#x02009;&#x000b1;&#x02009;standard error of the mean. Statistical differences were analyzed using either Student's <italic toggle="yes">t</italic>&#x02010;test or one&#x02010;way analysis of variance (ANOVA) test. All statistical analyses were conducted using IBM SPSS Statistics 23 (IBM, New York, USA) and GraphPad Prism 9 (GraphPad, San Diego, USA). A significance level of <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="ame212507-sec-0012"><label>3</label><title>RESULTS</title><sec id="ame212507-sec-0013"><label>3.1</label><title>Decreased <styled-content style="fixed-case" toggle="no">
<italic toggle="yes">ZEB1</italic>
</styled-content> expression and type&#x02010;H vessel formation were detected in the femoral heads of <styled-content style="fixed-case" toggle="no">SONFH</styled-content> patients</title><p>The femoral heads of SONFH and femur neck fracture patients were collected to detect the expression of <italic toggle="yes">ZEB1</italic> and the development of type&#x02010;H vessels. IF results demonstrated a significant decrease in the expression of <italic toggle="yes">ZEB1</italic> in the SONFH group compared to the control group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01) (Figure&#x000a0;<xref rid="ame212507-fig-0001" ref-type="fig">1A,B</xref>). Additionally, the expression levels of <italic toggle="yes">EMCN</italic> and <italic toggle="yes">CD31</italic>, which serve as biomarkers for type&#x02010;H vessels, were significantly lower in the SONFH group compared to the control group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) (Figure&#x000a0;<xref rid="ame212507-fig-0001" ref-type="fig">1C&#x02013;E</xref>). The findings indicate reduced expression levels of <italic toggle="yes">ZEB1</italic> and impaired formation of type&#x02010;H vessels in SONFH. Further investigations are required to elucidate the roles of these genes in the pathogenesis of SONFH.</p><fig position="float" fig-type="FIGURE" id="ame212507-fig-0001"><label>FIGURE 1</label><caption><p>
<italic toggle="yes">ZEB1</italic> and type&#x02010;H vessel expression are decreased in the femoral heads of SONFH patients. (A) Representative immunofluorescence (IF) images of <italic toggle="yes">ZEB1</italic> (red) in the femoral head. Scale bar: 50&#x02009;&#x003bc;m. (B) Relative fluorescence intensity of <italic toggle="yes">ZEB1</italic>. (C) Representative IF images of <italic toggle="yes">EMCN</italic> (red) and <italic toggle="yes">CD31</italic> (green) in the femoral heads. Scale bar: 50&#x02009;&#x003bc;m. (D, E) Relative fluorescence intensity of (D) <italic toggle="yes">EMCN</italic> and (E) <italic toggle="yes">CD31</italic>. <italic toggle="yes">CD31</italic>, platelet endothelial cell adhesion molecule&#x02010;1; <italic toggle="yes">EMCN</italic>, endomucin; SONFH, steroid&#x02010;induced osteonecrosis of the femoral head; <italic toggle="yes">ZEB1</italic>, zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01. *Compared with the control group.</p></caption><graphic xlink:href="AME2-7-802-g005" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="ame212507-sec-0014"><label>3.2</label><title>
<styled-content style="fixed-case" toggle="no">SONFH</styled-content> and <styled-content style="fixed-case" toggle="no">
<italic toggle="yes">ZEB1</italic>
</styled-content> knockdown models were successfully developed</title><p>The SONFH model was successfully developed, and there was a decrease in the number of bone trabeculae in the femoral head. The amount of hematopoietic tissue in the bone marrow also decreased, and the tissue was replaced by adipocytes. Moreover, a significant increase in the proportion of empty lacunae was observed (Figure&#x000a0;<xref rid="ame212507-fig-0002" ref-type="fig">2A,B</xref>). Then, the levels of <italic toggle="yes">ZEB1</italic> in the control, SONFH, and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> groups were detected via IF and RT&#x02010;qPCR. A decreased expression of <italic toggle="yes">ZEB1</italic> in type&#x02010;H vessels was detected in the SONFH group and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> group using IF (Figure&#x000a0;<xref rid="ame212507-fig-0002" ref-type="fig">2C,D</xref>). Moreover, the total <italic toggle="yes">ZEB1</italic> level in the femoral heads of the mice was detected using RT&#x02010;qPCR. Low <italic toggle="yes">ZEB1</italic> levels were detected in the SONFH group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), and lower <italic toggle="yes">ZEB1</italic> levels were detected in the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Figure&#x000a0;<xref rid="ame212507-fig-0002" ref-type="fig">2E</xref>), which indicated decreased <italic toggle="yes">ZEB1</italic> expression in SONFH patients and successful <italic toggle="yes">ZEB1</italic> knockdown in the SONFH+si&#x02010;ZEB1 group.</p><fig position="float" fig-type="FIGURE" id="ame212507-fig-0002"><label>FIGURE 2</label><caption><p>SONFH and <italic toggle="yes">ZEB1</italic> knockdown mouse models were successfully constructed. (A) The SONFH model was successfully constructed. Representative HE (hematoxylin and eosin)&#x02013;stained images of mouse femoral heads are presented. The empty lacuna and lipoid degeneraria are indicated by red arrows and black arrows, respectively. Scale bar: 100&#x02009;&#x003bc;m for 100&#x000d7; and 50&#x02009;&#x003bc;m for 200&#x000d7;. (B) The percentage of empty lacunae was calculated. (C, D) <italic toggle="yes">ZEB1</italic> expression levels were measured using immunofluorescence. (E) The mRNA expression of <italic toggle="yes">ZEB1</italic> was detected using RT&#x02010;qPCR (quantitative real&#x02010;time polymerase chain reaction). <italic toggle="yes">CD31</italic>, platelet endothelial cell adhesion molecule&#x02010;1; SONFH, steroid&#x02010;induced osteonecrosis of the femoral head; <italic toggle="yes">ZEB1</italic>, zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 and ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001; <sup>##</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 and <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001. *Compared with the control group, <sup>#</sup>compared in the SONFH and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> groups.</p></caption><graphic xlink:href="AME2-7-802-g002" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="ame212507-sec-0015"><label>3.3</label><title>
<styled-content style="fixed-case" toggle="no">
<italic toggle="yes">ZEB1</italic>
</styled-content> could regulate the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway in&#x000a0;vitro and in&#x000a0;vivo</title><p>In vitro, HUVECs were successfully transfected with lentivirus to knock down <italic toggle="yes">ZEB1</italic>, which was confirmed using RT&#x02010;qPCR (Figure&#x000a0;<xref rid="ame212507-fig-0003" ref-type="fig">3A</xref>). Then, the expression of <italic toggle="yes">&#x003b2;&#x02010;catenin</italic> and <italic toggle="yes">TCF&#x02010;4</italic>, key genes in the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway, was also detected using RT&#x02010;qPCR, and the results demonstrated that the expression of <italic toggle="yes">&#x003b2;&#x02010;catenin</italic> was significantly decreased after <italic toggle="yes">ZEB1</italic> was knocked down (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01), as shown in Figure&#x000a0;<xref rid="ame212507-fig-0003" ref-type="fig">3B</xref>. Similarly, the expression level of <italic toggle="yes">TCF&#x02010;4</italic> was also decreased in the si&#x02010;<italic toggle="yes">ZEB1</italic> group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01) (Figure&#x000a0;<xref rid="ame212507-fig-0003" ref-type="fig">3C</xref>).</p><fig position="float" fig-type="FIGURE" id="ame212507-fig-0003"><label>FIGURE 3</label><caption><p>
<italic toggle="yes">ZEB1</italic> could regulate the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway both in&#x000a0;vitro and in&#x000a0;vivo. (A) Relative mRNA (messenger RNA) expression of <italic toggle="yes">ZEB1</italic> in HUVECs (human umbilical vein endothelial cells). (B, C) The relative mRNA expression levels of <italic toggle="yes">&#x003b2;&#x02010;catenin</italic> and <italic toggle="yes">TCF&#x02010;4</italic> in HUVECs were measured. (D&#x02013;H) Relative protein expression levels of <italic toggle="yes">&#x003b2;&#x02010;catenin</italic>, <italic toggle="yes">cyclin D1</italic>, and <italic toggle="yes">C&#x02010;Myc</italic> in SONFH mice. <italic toggle="yes">TCF&#x02010;4</italic>, transcription factor 4; SONFH, steroid&#x02010;induced osteonecrosis of the femoral head; <italic toggle="yes">ZEB1</italic>, zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, and ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001; <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 and <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001. *Compared with the control group, <sup>#</sup>compared in the SONFH, SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>, and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>+LiCl groups.</p></caption><graphic xlink:href="AME2-7-802-g001" position="anchor" id="jats-graphic-7"/></fig><p>Moreover, to further examine the association between <italic toggle="yes">ZEB1</italic> and the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway in&#x000a0;vivo, an activator of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway was employed. As shown in Figure&#x000a0;<xref rid="ame212507-fig-0003" ref-type="fig">3D&#x02013;H</xref>, the expressions of <italic toggle="yes">&#x003b2;&#x02010;catenin</italic>, <italic toggle="yes">cyclin D1</italic>, and <italic toggle="yes">C&#x02010;Myc</italic> in the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway were lower in the SONFH group than in the control group and were greatly lower when the expression of <italic toggle="yes">ZEB1</italic> was decreased further (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Moreover, the downregulation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway caused by the decreased expression of <italic toggle="yes">ZEB1</italic> was reversed after the administration of LiCl (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Therefore, we concluded that a decrease in <italic toggle="yes">ZEB1</italic> could negatively regulate the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway.</p></sec><sec id="ame212507-sec-0016"><label>3.4</label><title>Decreased <styled-content style="fixed-case" toggle="no">
<italic toggle="yes">ZEB1</italic>
</styled-content> expression could reduce the formation of type&#x02010;H vessels via the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway</title><p>It was found that <italic toggle="yes">ZEB1</italic> expression and type&#x02010;H vessel distribution decreased in SONFH patients, but the specific mechanism involved remains unclear. Therefore, <italic toggle="yes">ZEB1</italic> was knocked down to observe the development of type&#x02010;H vessels. The IF results showed that the expression of type&#x02010;H vessel&#x02010;related biomarkers was largely lower in the SONFH group than in the control group, and there were lower expression levels of type&#x02010;H vessel&#x02010;related biomarkers after <italic toggle="yes">ZEB1</italic> knockdown (Figure&#x000a0;<xref rid="ame212507-fig-0004" ref-type="fig">4A&#x02013;C</xref>). However, the expression levels of these biomarkers increased when the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway was activated (Figure&#x000a0;<xref rid="ame212507-fig-0004" ref-type="fig">4A&#x02013;C</xref>). Therefore, we concluded that the formation of type&#x02010;H vessels was mediated by the expression of <italic toggle="yes">ZEB1</italic> via the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway.</p><fig position="float" fig-type="FIGURE" id="ame212507-fig-0004"><label>FIGURE 4</label><caption><p>Decreased <italic toggle="yes">ZEB1</italic> expression could reduce the formation of type&#x02010;H vessels via the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway. (A) Representative immunofluorescence images showing a decrease in the number of type&#x02010;H vessels. Scale bar: 50&#x02009;&#x003bc;m. (B) Quantitative calculation of the expression of <italic toggle="yes">EMCN</italic>. (C) Quantitative calculation of <italic toggle="yes">CD31</italic> expression. <italic toggle="yes">CD31</italic>, platelet endothelial cell adhesion molecule&#x02010;1; <italic toggle="yes">EMCN</italic>, endomucin; SONFH, steroid&#x02010;induced osteonecrosis of the femoral head; <italic toggle="yes">ZEB1</italic>, zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, and ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001; <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 and <sup>##</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01. *Compared with the control group, <sup>#</sup>compared in the SONFH, SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>, and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>+LiCl groups.</p></caption><graphic xlink:href="AME2-7-802-g004" position="anchor" id="jats-graphic-9"/></fig></sec><sec id="ame212507-sec-0017"><label>3.5</label><title>Decreased <styled-content style="fixed-case" toggle="no">
<italic toggle="yes">ZEB1</italic>
</styled-content> expression could impair type&#x02010;H vessel&#x02010;mediated angiogenesis by regulating the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway</title><p>Micro&#x02010;CT&#x02010;based angiography was performed to further assess the number and density of vessels in the femoral heads. Figure&#x000a0;<xref rid="ame212507-fig-0005" ref-type="fig">5A</xref> shows that there were fewer vessels in the SONFH group than in the control group, and the number of vessels further decreased after <italic toggle="yes">ZEB1</italic> was knocked down. However, there were more vessels in the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> group when the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway was activated by LiCl (Figure&#x000a0;<xref rid="ame212507-fig-0005" ref-type="fig">5A&#x02013;C</xref>). Moreover, the level of <italic toggle="yes">VEGF</italic>, which can promote angiogenesis, was measured using IF. The findings indicated that the level of <italic toggle="yes">VEGF</italic> in the SONFH group was significantly lower than that in the control group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), and the decrease was even greater in the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Conversely, the activation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway by LiCl led to a significant increase in <italic toggle="yes">VEGF</italic> expression (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Figure&#x000a0;<xref rid="ame212507-fig-0005" ref-type="fig">5D,E</xref>).</p><fig position="float" fig-type="FIGURE" id="ame212507-fig-0005"><label>FIGURE 5</label><caption><p>Type H&#x02010;mediated angiogenesis decreases due to a decrease in <italic toggle="yes">ZEB1</italic>, which causes impairment of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway. (A) Representative micro&#x02010;CT (computed tomography)&#x02013;based angiography images are presented. (B, C) The vessel volume fraction and relative vessel density were calculated. (D) Representative immunofluorescence images showing the expression of <italic toggle="yes">VEGF</italic> in type&#x02010;H vessels (yellow regions). Scale bar: 50&#x02009;&#x003bc;m. (E) The levels of <italic toggle="yes">VEGF</italic> in all groups were calculated. (F&#x02013;H) The expression levels of endostain and <italic toggle="yes">VEGF</italic> in HUVECs (human umbilical vein endothelial cells) were measured using Western blotting. <italic toggle="yes">CD31</italic>, platelet endothelial cell adhesion molecule&#x02010;1; SONFH, steroid&#x02010;induced osteonecrosis of the femoral head; <italic toggle="yes">VEGF</italic>, vascular endothelial growth factor; <italic toggle="yes">ZEB1</italic>, zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, and ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001; <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, and <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001. *Compared with the control group, <sup>#</sup>compared in the SONFH, SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>, and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>+LiCl groups; or in the si&#x02010;<italic toggle="yes">ZEB1</italic>,control+Bio and si&#x02010;<italic toggle="yes">ZEB1</italic>+Bio groups.</p></caption><graphic xlink:href="AME2-7-802-g008" position="anchor" id="jats-graphic-11"/></fig><p>The expression of angiogenesis&#x02010;related genes, including endostatin (<italic toggle="yes">ES</italic>) and <italic toggle="yes">VEGF</italic>, was detected in HUVECs. <italic toggle="yes">VEGF</italic> promoted angiogenesis in HUVECs, whereas <italic toggle="yes">ES</italic> exhibited a negative effect. Western blotting results showed that, compared with those in the control group, the expression of <italic toggle="yes">ES</italic> was elevated, whereas the expression of <italic toggle="yes">VEGF</italic> was lower (Figure&#x000a0;<xref rid="ame212507-fig-0005" ref-type="fig">5F&#x02013;H</xref>), indicating that <italic toggle="yes">ZEB1</italic> knockdown impaired angiogenesis. However, treatment with BIO, a <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway activator, significantly improved angiogenesis in HUVECs, as indicated by a decreased level of <italic toggle="yes">ES</italic> and increased expression of <italic toggle="yes">VEGF</italic> compared with those in the si&#x02010;<italic toggle="yes">ZEB1</italic> group (Figure&#x000a0;<xref rid="ame212507-fig-0005" ref-type="fig">5F&#x02013;H</xref>).</p><p>All these results suggested that the inhibition of <italic toggle="yes">ZEB1</italic> could attenuate angiogenesis. Conversely, activation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway could ameliorate impaired angiogenesis.</p></sec><sec id="ame212507-sec-0018"><label>3.6</label><title>Decreased <styled-content style="fixed-case" toggle="no">
<italic toggle="yes">ZEB1</italic>
</styled-content> expression could impair type&#x02010;H vessel&#x02010;mediated osteogenesis by regulating the Wnt/&#x003b2;&#x02010;catenin pathway</title><p>The bone microstructure of the femoral heads was analyzed using micro&#x02010;CT and is shown in Figure&#x000a0;<xref rid="ame212507-fig-0006" ref-type="fig">6A</xref>. Compared to the control group, the BMD, BV, BV/TV, and Tb.N in the SONFH group were significantly lower. These parameters were lower after <italic toggle="yes">ZEB1</italic> was knocked down (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) but significantly increased when LiCl activated the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) (Figure&#x000a0;<xref rid="ame212507-fig-0006" ref-type="fig">6B&#x02013;E</xref>). These results showed that <italic toggle="yes">ZEB1</italic> could strongly reduce bone mass and change the microstructure of femoral heads. Furthermore, in the present study, we detected Tb.Th; however, no significant difference was observed in the SONFH group compared to the control group. In the si&#x02010;<italic toggle="yes">ZEB1</italic> group, the level of Tb.Th significantly decreased compared with that in the control group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01) and improved substantially after the activation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) (Figure&#x000a0;<xref rid="ame212507-fig-0006" ref-type="fig">6F</xref>), suggesting that only a substantial decrease in <italic toggle="yes">ZEB1</italic> might change the thickness of the trabecular bone. However, no significant change was found in any of the groups for Ct.Th (Figure&#x000a0;<xref rid="ame212507-fig-0006" ref-type="fig">6G</xref>). These results revealed that the trabecular region was seriously affected by changes in <italic toggle="yes">ZEB1</italic> expression in the femoral heads.</p><fig position="float" fig-type="FIGURE" id="ame212507-fig-0006"><label>FIGURE 6</label><caption><p>Micro&#x02010;CT (computed tomography) images and parameters for femoral heads in different groups. (A) Representative micro&#x02010;CT images of all groups. (B&#x02010;G) Micro&#x02010;CT parameters, including BMD, BV, BV/TV, Tb.N, Tb.Th, and Ct.Th, are presented. BMD, bone mineral density; BV, bone volume; BV/TV, percentage bone volume; Ct.Th, cortical thickness; SONFH, steroid&#x02010;induced osteonecrosis of the femoral head; Tb.N, trabecular number; Tb.Th, trabecular thickness; <italic toggle="yes">ZEB1</italic>, zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, and ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001; <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 and <sup>##</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01. *Compared with the control group, <sup>#</sup>compared in the SONFH, SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>, and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>+LiCl groups.</p></caption><graphic xlink:href="AME2-7-802-g006" position="anchor" id="jats-graphic-13"/></fig><p>Additionally, the bone formation rate was assayed using double calcein labeling (Figure&#x000a0;<xref rid="ame212507-fig-0007" ref-type="fig">7A</xref>). The results showed that the distance between the green signals in the SONFH and the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> groups was shorter than that in the control and the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>+LiCl groups. The mineral apposition rate (MAR), defined as the ratio of distance to time, was calculated to quantify the bone formation rate. Similarly, compared with that in the SONFH group, the MAR in the SONFH and the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> groups significantly decreased (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), but no significant difference was detected when <italic toggle="yes">ZEB1</italic> was knocked down. After the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway was activated, the MAR significantly increased compared with that in the SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic> group (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) (Figure&#x000a0;<xref rid="ame212507-fig-0007" ref-type="fig">7B</xref>). The expression of osteogenesis&#x02010;related genes, including <italic toggle="yes">ALP</italic>, <italic toggle="yes">Osterix</italic>, and <italic toggle="yes">Runx2</italic>, was also measured using IHC (Figure&#x000a0;<xref rid="ame212507-fig-0007" ref-type="fig">7C&#x02013;F</xref>). ALP expression was significantly decreased in the SONFH group compared to the control group, and this reduction was further enhanced after the knockdown of <italic toggle="yes">ZEB1</italic> (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01). However, the application of LiCl resulted in a significant increase in <italic toggle="yes">ALP</italic> expression. Additionally, the expression of <italic toggle="yes">Osterix</italic> and <italic toggle="yes">Runx2</italic> exhibited similar patterns.</p><fig position="float" fig-type="FIGURE" id="ame212507-fig-0007"><label>FIGURE 7</label><caption><p>Type H&#x02010;mediated osteogenesis decreased due to the downregulation of <italic toggle="yes">ZEB1</italic>, which impaired the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway. (A) Representative image in all groups stained with calcein. The distance between two green labels was positively related to the bone mineralization rate. Scale bar: 20&#x02009;&#x003bc;m. (B) MAR was calculated for all groups. (C&#x02013;F) Representative immunohistochemical images and statistical analysis of <italic toggle="yes">ALP</italic>, <italic toggle="yes">Osterix</italic>, and <italic toggle="yes">Runx2</italic> expression. Scale bar: 100&#x02009;&#x003bc;m for 100&#x000d7; and 50&#x02009;&#x003bc;m for 400&#x000d7;. ALP, alkaline phosphatase; MAR, mineral apposition rate; <italic toggle="yes">Runx2</italic>, runt&#x02010;related transcription factor 2; SONFH, steroid&#x02010;induced osteonecrosis of the femoral head; <italic toggle="yes">ZEB1</italic>, zinc&#x02010;finger E&#x02010;box&#x02010;binding homeobox&#x02010;1. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, and ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001; <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 . *Compared with the control group, <sup>#</sup>compared in&#x000a0;the SONFH, SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>, and SONFH+si&#x02010;<italic toggle="yes">ZEB1</italic>+LiCl groups.</p></caption><graphic xlink:href="AME2-7-802-g007" position="anchor" id="jats-graphic-15"/></fig></sec></sec><sec sec-type="discussion" id="ame212507-sec-0019"><label>4</label><title>DISCUSSION</title><p>Currently, prolonged and widespread use of glucocorticoids has emerged as a key risk factor for the development of ONFH. Although core decompression, vascularized bone grafts, and other methods have been applied for the treatment of SONFH, the therapeutic efficacy of these methods has been unsatisfactory, and the major procedure for treating SONFH is total hip arthroplasty during the late period, which places great burdens on individuals and society.<xref rid="ame212507-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> Therefore, it is essential to explore the mechanism of this disease and put in place early intervention measures. In this study, we confirmed that a reduction in <italic toggle="yes">ZEB1</italic> expression can hinder the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway, causing a decrease in the development of type&#x02010;H vessels. This impairment of angiogenesis and osteogenesis coupling facilitated by type&#x02010;H vessels ultimately speeds up the progression of SONFH. These findings provide a fresh perspective on the pathogenesis of SONFH.</p><p>
<italic toggle="yes">ZEB1</italic> is strongly associated with the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway in numerous diseases. It was demonstrated that <italic toggle="yes">ZEB1</italic> could trigger the activation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway by repressing <italic toggle="yes">Wif1</italic>, ultimately alleviating vascular deformities.<xref rid="ame212507-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Moreover, Zhao et&#x000a0;al. demonstrated that <italic toggle="yes">ZEB1</italic> could enhance the transcription of <italic toggle="yes">ELK3</italic>, a member of the ternary complex factor, to stimulate the activation of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway.<xref rid="ame212507-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Another study revealed that <italic toggle="yes">ZEB1</italic> could regulate the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway to act on insubstantial hepatic stellate cells and liver fibrosis.<xref rid="ame212507-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> In the present study, the impaired <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway was identified in SONFH, and this pathway was further inhibited after <italic toggle="yes">ZEB1</italic> was knocked down. However, the specific underlying mechanism is unclear and requires additional research.</p><p>Type&#x02010;H vessels, distinguished by elevated expression levels of <italic toggle="yes">EMCN</italic> and <italic toggle="yes">CD31</italic>, are predominantly situated in close proximity to the growth plate at the metaphyseal end and within the periosteum of bone. These vessels are virtually absent in other tissues and play a crucial role in facilitating the coordination of angiogenesis and osteogenesis.<xref rid="ame212507-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
<italic toggle="yes">ZEB1</italic> was predominantly detected in type&#x02010;H vessels, and the lack of <italic toggle="yes">ZEB1</italic> in endothelial cells could decrease the development of type&#x02010;H vessels and bone.<xref rid="ame212507-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Additionally, stimulating <italic toggle="yes">ZEB1/Notch1</italic> facilitates the development of type&#x02010;H vessels and orchestrates the integration of osteogenesis and angiogenesis, ultimately promoting bone regeneration.<xref rid="ame212507-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> In the present study, decreased levels of <italic toggle="yes">ZEB1</italic> were detected in the femoral heads of SONFH patients and mice. Moreover, the quantity of type&#x02010;H vessels and the degree of coupling between angiogenesis and osteogenesis decreased after the knockdown of <italic toggle="yes">ZEB1</italic> in the femoral heads of mice. Although there are a few studies on the role of <italic toggle="yes">ZEB1</italic> in SONFH, the functions of <italic toggle="yes">ZEB1</italic> in the formation of bones and vessels have been well illustrated. For example, <italic toggle="yes">ZEB1</italic> was found to promote the generation of osteoblasts and inhibit the differentiation of osteoclasts, ultimately reducing the occurrence of postmenopausal osteoporosis.<xref rid="ame212507-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Similarly, Tao et&#x000a0;al. constructed a polymeric coating on a &#x003b2;&#x02010;tricalcium phosphate scaffold loaded with <italic toggle="yes">ZEB1</italic> and demonstrated that <italic toggle="yes">ZEB1</italic> could stimulate bone defect healing by enhancing angiogenesis and osteogenesis while suppressing osteoclast formation.<xref rid="ame212507-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> However, <italic toggle="yes">ZEB1</italic> was also found to block osteoblastic differentiation during normal bone development.<xref rid="ame212507-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Other researchers found that silencing <italic toggle="yes">ZEB1</italic> in BMSCs enhanced osteogenic function in&#x000a0;vitro, whereas there was an inverse relationship between <italic toggle="yes">ZEB1</italic> expression and bone mass as well as bone formation in postmenopausal women in&#x000a0;vivo.<xref rid="ame212507-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> The differences in the conclusions regarding the roles of <italic toggle="yes">ZEB1</italic> among various studies might be attributed to differences in the subjects and animal models used. The present study revealed that a decrease in <italic toggle="yes">ZEB1</italic> might accelerate the process of SONFH by inhibiting angiogenesis and osteogenesis.</p><p>In this study, we detected the formation of type&#x02010;H vessels in the femoral heads and found decreased expression in SONFH patients and in a mouse model. Type&#x02010;H vessels have been indicated to reduce bone loss and promote bone generation in previous studies.<xref rid="ame212507-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="ame212507-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Although platelet&#x02010;derived growth factor&#x02010;BB was found to promote reparative osteogenesis in SONFH by targeting type&#x02010;H vessels,<xref rid="ame212507-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> studies exploring the roles of type&#x02010;H vessels in SONFH are rare. Furthermore, our research revealed that the coordination between angiogenesis and osteogenesis was impaired in patients with SONFH, attributed to the reduced quantity of type&#x02010;H vessels. Our initial investigation demonstrated that <italic toggle="yes">ES</italic> could suppress angiogenesis and osteogenesis in the femoral head, expediting the progression of SONFH.<xref rid="ame212507-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> Li et&#x000a0;al. constructed a scaffold and revealed that it could ameliorate SONFH by enhancing angiogenesis and bone regeneration via the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway.<xref rid="ame212507-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> In another previous study, after combination of the parathyroid hormone and core compression, there was an increase in the number of vessels within the tunnels, along with elevated expression levels of <italic toggle="yes">BMP&#x02010;2</italic>, <italic toggle="yes">Runx2</italic>, and <italic toggle="yes">VEGF</italic> in SONFH rabbits.<xref rid="ame212507-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> Moreover, Sun et&#x000a0;al. revealed a decrease in the MAR, BMD, BV/TV, and Tb.N in SONFH, as detected using double calcein labeling and micro&#x02010;CT, which was consistent with our research.<xref rid="ame212507-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Nevertheless, these studies have mainly concentrated on impaired bone or vessel formation rather than the coordination of vascularization and bone formation, which are regulated by type&#x02010;H vessels.</p><p>This current study has several limitations. First, a decrease in <italic toggle="yes">ZEB1</italic> was shown to hinder the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway and diminish the formation of type&#x02010;H vessels, resulting in the development of SONFH. Conversely, administering an activator of the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway could alleviate these conditions. We subsequently attempted to upregulate the expression of <italic toggle="yes">ZEB1</italic>, but the constructed model was unstable and could not be used for further analysis. Therefore, it remains unclear whether the upregulation of <italic toggle="yes">ZEB1</italic> expression can delay the development of SONFH due to our inability to establish a model for <italic toggle="yes">ZEB1</italic> overexpression. Additionally, we proved that <italic toggle="yes">ZEB1</italic> could affect type&#x02010;H vessels via the Wnt/&#x003b2;&#x02010;catenin pathway, but the specific mechanism through which <italic toggle="yes">ZEB1</italic> acts on the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway is unclear and requires additional research.</p><p>This study revealed that the expression of <italic toggle="yes">ZEB1</italic> and the formation of type&#x02010;H vessels in the femoral heads decreased in SONFH. Further analysis revealed that a decrease in <italic toggle="yes">ZEB1</italic> could impair the formation of type&#x02010;H vessels and mediate angiogenesis and osteogenesis via the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway. Additionally, the application of LiCl activated the <italic toggle="yes">Wnt/&#x003b2;&#x02010;catenin</italic> pathway and enhanced the number of type&#x02010;H vessels, ultimately alleviating SONFH, which provides a novel strategy for clarifying the pathogenesis of SONFH.</p></sec><sec id="ame212507-sec-0025"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Guangyang Zhang:</bold> Conceptualization; formal analysis; methodology; writing &#x02013; original draft. <bold>Yuanqing Cai:</bold> Data curation; writing &#x02013; original draft. <bold>Jialin Liang:</bold> Resources; software. <bold>Zhaopu Jing:</bold> Investigation; resources. <bold>Wang Wei:</bold> Data curation; visualization. <bold>Leifeng Lv:</bold> Software; validation; visualization. <bold>Xiaoqian Dang:</bold> Funding acquisition; methodology; writing &#x02013; review and editing. <bold>Qichun Song:</bold> Formal analysis; methodology; writing &#x02013; review and editing.</p></sec><sec id="ame212507-sec-0021"><title>FUNDING INFORMATION</title><p>This study received funding from the National Natural Science Foundation of China (grant number 82002311), the China Postdoctoral Science Foundation (grant number 2021M692575), and the Fundamental Research Funds for the Central Universities (grant number xzy022024016).</p></sec><sec sec-type="COI-statement" id="ame212507-sec-0022"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors confirm that the research was conducted without any commercial or financial relationships that could be perceived as a potential conflict of interest.</p></sec><sec id="ame212507-sec-0023"><title>ETHICS APPROVAL AND CONSENT TO PARTICIPATE</title><p>The animal study was reviewed and approved by the Ethics Committee of Xi'an Jiao Tong University Health Science Center (2020&#x02013;938), and the clinical research was approved by the Ethics Committee of the Second Affiliated Hospital of Xi'an Jiaotong University (2023213). The investigation was carried out following the rules of the Declaration of Helsinki.</p></sec><sec id="ame212507-sec-0024"><title>PATIENT CONSENT FOR PUBLICATION</title><p>All patients participating in this research provided consent for publication, and written informed consent was obtained from all individuals. All procedures conducted in this study adhered to the applicable guidelines and regulations.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="ame212507-supitem-0001" position="float" content-type="local-data"><caption><p>
Table&#x000a0;S1.
</p></caption><media xlink:href="AME2-7-802-s001.pdf"/></supplementary-material></sec></body><back><ack id="ame212507-sec-0020"><title>ACKNOWLEDGMENTS</title><p>Not applicable.</p></ack><ref-list content-type="cited-references" id="ame212507-bibl-0001"><title>REFERENCES</title><ref id="ame212507-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ame212507-cit-0001">
<string-name>
<surname>Mont</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Cherian</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Sierra</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Lieberman</surname>
<given-names>JR</given-names>
</string-name>. <article-title>Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten&#x02010;year update</article-title>. <source>J Bone Joint Surg Am</source>. <year>2015</year>;<volume>97</volume>:<fpage>1604</fpage>&#x02010;<lpage>1627</lpage>.<pub-id pub-id-type="pmid">26446969</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ame212507-cit-0002">
<string-name>
<surname>Zhao</surname>
<given-names>D&#x02010;W</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population: results from a nationally representative survey</article-title>. <source>Chin Med J</source>. <year>2015</year>;<volume>128</volume>:<fpage>2843</fpage>&#x02010;<lpage>2850</lpage>.<pub-id pub-id-type="pmid">26521779</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ame212507-cit-0003">
<string-name>
<surname>Wang</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>. <article-title>The pathogenesis of steroid&#x02010;induced osteonecrosis of the femoral head: a systematic review of the literature</article-title>. <source>Gene</source>. <year>2018</year>;<volume>671</volume>:<fpage>103</fpage>&#x02010;<lpage>109</lpage>.<pub-id pub-id-type="pmid">29859289</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ame212507-cit-0004">
<string-name>
<surname>Peng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Crane</surname>
<given-names>JL</given-names>
</string-name>. <article-title>Type&#x02010;H blood vessels in bone modeling and remodeling</article-title>. <source>Theranostics</source>. <year>2020</year>;<volume>10</volume>:<fpage>426</fpage>&#x02010;<lpage>436</lpage>.<pub-id pub-id-type="pmid">31903130</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ame212507-cit-0005">
<string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Occlusal force maintains alveolar bone homeostasis via type&#x02010;H angiogenesis</article-title>. <source>J Dent Res</source>. <year>2023</year>;<volume>102</volume>(<issue>12</issue>): <fpage>1356</fpage>&#x02010;<lpage>1365</lpage>.<pub-id pub-id-type="pmid">37786932</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ame212507-cit-0006">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>SLIT guidance ligand 3 (SLIT3) loaded in hydrogel microparticles enhances the tendon&#x02010;bone healing through promotion of type&#x02010;H vessel formation: an experimental study in mice</article-title>. <source>Int J Mol Sci</source>. <year>2</year>;<volume>13638</volume>.</mixed-citation></ref><ref id="ame212507-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ame212507-cit-0007">
<string-name>
<surname>Ruan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>T&#x02010;F</given-names>
</string-name>, et&#x000a0;al. <article-title>Metformin accelerates bone fracture healing by promoting type&#x02010;H vessel formation through inhibition of YAP1/TAZ expression</article-title>. <source>Bone Res</source>. <year>2023</year>;<volume>11</volume>:<elocation-id>45</elocation-id>.<pub-id pub-id-type="pmid">37587136</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ame212507-cit-0008">
<string-name>
<surname>Qiu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>3D biomimetic calcified cartilaginous callus that induces type&#x02010;H vessels formation and Osteoclastogenesis</article-title>. <source>Adv Sci (Weinh)</source>. <year>2023</year>;<volume>10</volume>:<elocation-id>e2207089</elocation-id>.<pub-id pub-id-type="pmid">36999832</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ame212507-cit-0009">
<string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ouyang</surname>
<given-names>H</given-names>
</string-name>. <article-title>High levels of GSK&#x02010;3&#x003b2; signalling reduce osteogenic differentiation of stem cells in osteonecrosis of femoral head</article-title>. <source>J Biochem</source>. <year>2018</year>;<volume>163</volume>:<fpage>243</fpage>&#x02010;<lpage>251</lpage>.<pub-id pub-id-type="pmid">29136173</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ame212507-cit-0010">
<string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Glycyrrhizic acid alters the hyperoxidative stress&#x02010;induced differentiation commitment of MSCs by activating the Wnt/&#x003b2;&#x02010;catenin pathway to prevent SONFH</article-title>. <source>Food Funct</source>. <year>2023</year>;<volume>14</volume>:<fpage>946</fpage>&#x02010;<lpage>960</lpage>.<pub-id pub-id-type="pmid">36541285</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ame212507-cit-0011">
<string-name>
<surname>Zhang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>M</given-names>
</string-name>. <article-title>Astragalus polysaccharide ameliorates steroid&#x02010;induced osteonecrosis of the femoral head by regulating miR&#x02010;200b&#x02010;3p&#x02010;mediated Wnt/&#x003b2;&#x02010;catenin signaling pathway via inhibiting SP1 expression: astragalus polysaccharide regulates SONFH via SP1</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2023</year>;<volume>24</volume>:<fpage>369</fpage>.<pub-id pub-id-type="pmid">37165386</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ame212507-cit-0012">
<string-name>
<surname>Shen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>EGFL6 regulates angiogenesis and osteogenesis in distraction osteogenesis via Wnt/&#x003b2;&#x02010;catenin signaling</article-title>. <source>Stem Cell Res Ther</source>. <year>2021</year>;<volume>12</volume>:<fpage>415</fpage>.<pub-id pub-id-type="pmid">34294121</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ame212507-cit-0013">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>A novel decellularized matrix of Wnt signaling&#x02010;activated osteocytes accelerates the repair of critical&#x02010;sized parietal bone defects with osteoclastogenesis, angiogenesis, and neurogenesis</article-title>. <source>Bioact Mater</source>. <year>2023</year>;<volume>21</volume>:<fpage>110</fpage>&#x02010;<lpage>128</lpage>.<pub-id pub-id-type="pmid">36093329</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ame212507-cit-0014">
<string-name>
<surname>Fu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>C&#x02010;F</given-names>
</string-name>, <string-name>
<surname>Ni</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>:<elocation-id>3210</elocation-id>.<pub-id pub-id-type="pmid">31324807</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ame212507-cit-0015">
<string-name>
<surname>Fu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>W&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Endothelial ZEB1 promotes angiogenesis&#x02010;dependent bone formation and reverses osteoporosis</article-title>. <source>Nat Commun</source>. <year>2020</year>;<volume>11</volume>:<elocation-id>460</elocation-id>.<pub-id pub-id-type="pmid">31974363</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ame212507-cit-0016">
<string-name>
<surname>Zeng</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>USP22 upregulates ZEB1&#x02010;mediated VEGFA transcription in hepatocellular carcinoma</article-title>. <source>Cell Death Dis</source>. <year>2023</year>;<volume>14</volume>:<elocation-id>194</elocation-id>.<pub-id pub-id-type="pmid">36906615</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ame212507-cit-0017">
<string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>ROS scavenging graphene&#x02010;based hydrogel enhances type&#x02010;H vessel formation and vascularized bone regeneration via ZEB1/Notch1 mediation</article-title>. <source>Macromol Biosci</source>. <year>2023</year>;<volume>23</volume>:<elocation-id>e2200502</elocation-id>.<pub-id pub-id-type="pmid">36637816</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ame212507-cit-0018">
<string-name>
<surname>S&#x000e1;nchez&#x02010;Till&#x000f3;</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>de Barrios</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Valls</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Darling</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Castells</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Postigo</surname>
<given-names>A</given-names>
</string-name>. <article-title>ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression</article-title>. <source>Oncogene</source>. <year>2015</year>;<volume>34</volume>:<fpage>5760</fpage>&#x02010;<lpage>5770</lpage>.<pub-id pub-id-type="pmid">26387539</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ame212507-cit-0019">
<string-name>
<surname>Li</surname>
<given-names>L&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J&#x02010;F</given-names>
</string-name>, <string-name>
<surname>Rong</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/&#x003b2;&#x02010;catenin signaling pathway</article-title>. <source>Acta Pharmacol Sin</source>. <year>2021</year>;<volume>42</volume>:<fpage>1676</fpage>&#x02010;<lpage>1689</lpage>.<pub-id pub-id-type="pmid">33514855</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ame212507-cit-0020">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>. <article-title>Comparison of current treatment strategy for osteonecrosis of the femoral head from the perspective of cell therapy</article-title>. <source>Front Cell Dev Biol</source>. <year>2023</year>;<volume>11</volume>:<elocation-id>995816</elocation-id>.<pub-id pub-id-type="pmid">37035246</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ame212507-cit-0021">
<string-name>
<surname>Yu</surname>
<given-names>QC</given-names>
</string-name>, <string-name>
<surname>Geng</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Preusch</surname>
<given-names>CB</given-names>
</string-name>, et&#x000a0;al. <article-title>Activation of Wnt/&#x003b2;&#x02010;catenin signaling by Zeb1 in endothelial progenitors induces vascular quiescence entry</article-title>. <source>Cell Rep</source>. <year>2022</year>;<volume>41</volume>:<elocation-id>111694</elocation-id>.<pub-id pub-id-type="pmid">36417861</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ame212507-cit-0022">
<string-name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>ELK3 mediated by ZEB1 facilitates the growth and metastasis of pancreatic carcinoma by activating the Wnt/&#x003b2;&#x02010;catenin pathway</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<elocation-id>700192</elocation-id>.<pub-id pub-id-type="pmid">34409034</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ame212507-cit-0023">
<string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>MicroRNA&#x02010;708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt/&#x003b2;&#x02010;catenin pathway</article-title>. <source>Eur J Pharmacol</source>. <year>2020</year>;<volume>871</volume>:<elocation-id>172927</elocation-id>.<pub-id pub-id-type="pmid">31962101</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ame212507-cit-0024">
<string-name>
<surname>Zhu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Q</given-names>
</string-name>. <article-title>ZEB1 regulates bone metabolism in osteoporotic rats through inducing POLDIP2 transcription</article-title>. <source>J Orthop Surg Res</source>. <year>2022</year>;<volume>17</volume>:<elocation-id>423</elocation-id>.<pub-id pub-id-type="pmid">36123704</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ame212507-cit-0025">
<string-name>
<surname>Tao</surname>
<given-names>S&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X&#x02010;R</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>W&#x02010;J</given-names>
</string-name>, et&#x000a0;al. <article-title>Polymeric coating on &#x003b2;&#x02010;TCP scaffolds provides immobilization of small extracellular vesicles with surface&#x02010;functionalization and ZEB1&#x02010;loading for bone defect repair in diabetes mellitus</article-title>. <source>Biomaterials</source>. <year>2022</year>;<volume>283</volume>:<elocation-id>121465</elocation-id>.<pub-id pub-id-type="pmid">35286850</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ame212507-cit-0026">
<string-name>
<surname>Ruh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stemmler</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Frisch</surname>
<given-names>I</given-names>
</string-name>, et&#x000a0;al. <article-title>The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma</article-title>. <source>J Pathol</source>. <year>2021</year>;<volume>254</volume>:<fpage>199</fpage>&#x02010;<lpage>211</lpage>.<pub-id pub-id-type="pmid">33675037</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ame212507-cit-0027">
<string-name>
<surname>Xu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>ZEB1 mediates bone marrow mesenchymal stem cell osteogenic differentiation partly via Wnt/&#x003b2;&#x02010;catenin signaling</article-title>. <source>Front Mol Biosci</source>. <year>2021</year>;<volume>8</volume>:<elocation-id>682728</elocation-id>.<pub-id pub-id-type="pmid">34109218</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ame212507-cit-0028">
<string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Kusumbe</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>. <article-title>Type&#x02010;H blood vessels in coupling angiogenesis&#x02010;osteogenesis and its application in bone tissue engineering</article-title>. <source>J Biomed Mater Res B Appl Biomater</source>. <year>2023</year>;<volume>111</volume>:<fpage>1434</fpage>&#x02010;<lpage>1446</lpage>.<pub-id pub-id-type="pmid">36880538</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ame212507-cit-0029">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Regulating type&#x02010;H vessel formation and bone metabolism via bone&#x02010;targeting Oral micro/Nano&#x02010;hydrogel microspheres to prevent bone loss</article-title>. <source>Adv Sci (Weinh)</source>. <year>2023</year>;<volume>10</volume>:<elocation-id>e2207381</elocation-id>.<pub-id pub-id-type="pmid">36967561</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ame212507-cit-0030">
<string-name>
<surname>Cao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>PDGF&#x02010;BB prevents destructive repair and promotes reparative osteogenesis of steroid&#x02010;associated osteonecrosis of the femoral head in rabbits</article-title>. <source>Bone</source>. <year>2023</year>;<volume>167</volume>:<elocation-id>116645</elocation-id>.<pub-id pub-id-type="pmid">36539110</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ame212507-cit-0031">
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Duan</surname>
<given-names>D&#x02010;P</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>Q&#x02010;C</given-names>
</string-name>. <article-title>The effect of endostatin on angiogenesis and osteogenesis of steroid&#x02010;induced osteonecrosis of the femoral head in a rabbit model</article-title>. <source>Acta Orthop Traumatol Turc</source>. <year>2022</year>;<volume>56</volume>:<fpage>178</fpage>&#x02010;<lpage>186</lpage>.<pub-id pub-id-type="pmid">35703505</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ame212507-cit-0032">
<string-name>
<surname>Li</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lei</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>P</given-names>
</string-name>. <article-title>Porous copper&#x02010; and lithium&#x02010;doped nano&#x02010;hydroxyapatite composite scaffold promotes angiogenesis and bone regeneration in the repair of glucocorticoids&#x02010;induced osteonecrosis of the femoral head</article-title>. <source>Biomed Mater</source>. <year>2021</year>;<volume>16</volume>:<elocation-id>065012</elocation-id>.</mixed-citation></ref><ref id="ame212507-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ame212507-cit-0033">
<string-name>
<surname>Zhou</surname>
<given-names>C&#x02010;H</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>J&#x02010;H</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>C&#x02010;C</given-names>
</string-name>, et&#x000a0;al. <article-title>PTH[1&#x02010;34] improves the effects of core decompression in early&#x02010;stage steroid&#x02010;associated osteonecrosis model by enhancing bone repair and revascularization</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>:<elocation-id>e0178781</elocation-id>.<pub-id pub-id-type="pmid">28562696</pub-id>
</mixed-citation></ref><ref id="ame212507-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ame212507-cit-0034">
<string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Activation of cannabinoid receptor 2 alleviates glucocorticoid&#x02010;induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply</article-title>. <source>Cell Death Dis</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>1035</elocation-id>.<pub-id pub-id-type="pmid">34718335</pub-id>
</mixed-citation></ref></ref-list></back></article>